[5] Topical GHK-Cu is generally considered well tolerated, yet therapy should be avoided in individuals with a known hypersensitivity to copper peptides or any vehicle component
While shortness of breath is not listed as a common adverse effect in FDA prescribing information or clinical trial data, understanding when breathing difficulties require medical attention remains essential
It is common to feel like you are walking through molasses or as if you need a mid-afternoon nap just to get through the day
The substance Rey-Pailhade had named philothion was re-encountered, isolated, and renamed in 1921 by the British biochemist Sir Frederick Gowland Hopkins, working at Cambridge
Mki-Arvela, P., Simakova, I
The peptide remains unregulated and is sold exclusively as a research compound through suppliers operating under not for human consumption labeling